Back to Results
First PageMeta Content
Cancer treatments / Oncology / Evidence-based medicine / Genetics / Personalized medicine / Chemotherapy / Clinical trial / Fluorouracil / Management of cancer / Medicine / Health / Pharmacology


FOR IMMEDIATE RELEASE Adrienne Choma, Saladax Biomedical, IncSaladax Biomedical Executes Exclusive Distribution Agreement with
Add to Reading List

Document Date: 2013-11-19 17:47:16

Open Document

File Size: 95,67 KB

Share Result on Facebook

City

Kyoto / /

Company

Saladax Biomedical Inc. / FALCO SD / Osaka Securities Exchange / FALCO SD HOLDINGS Co. Ltd. / Tokyo Stock Exchange / /

Country

Japan / United States / /

/

Event

Business Partnership / FDA Phase / /

IndustryTerm

food sanitation / offers specialty services / cancer treatment / healthcare service / testing services / /

MedicalCondition

cancer / colorectal cancer / breast cancer / /

MedicalTreatment

chemotherapy / /

Person

Salvatore Salamone / Nobuhisa Gondo / Adrienne Choma / /

Position

Scientific Director and General Manager / CEO / forward to a successful relationship / /

Product

fluorouracil / My-5-FU / /

Technology

diagnostic tests / chemotherapy / /

URL

http /

SocialTag